Reporter Staff
| This email address is being protected from spambots. You need JavaScript enabled to view it.
• Are you 18-70 years of age living with HIV, and want to be a part of a curative study?
• Is your viral load suppressed/undetectable?
• Are you able to receive an infusion or injection?
• Are you generally healthy?
• Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a HIV treatment study looking at an investigational way to effectively clear the HIV virus in areas of the body that standard antiretroviral treatment is unable to reach. You will receive one of two potential intervention methods. One intervention method is a broadly neutralizing antibody that is given to control growth of the HIV virus and to increase the body’s immune system response. The second intervention method is an injection (IL-15 Superagonist) designed to awaken the immune system, activate any dormant HIV virus, and then kill the virus. The duration of this study is approximately 84-112 weeks pending on which intervention method you receive. There is compensation at each study visit for time and travel.
Contact: If interested, please email kspraggins@uabmc.edu or call 205-934-9346
• Is your viral load suppressed/undetectable?
• Are you able to receive an infusion or injection?
• Are you generally healthy?
• Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a HIV treatment study looking at an investigational way to effectively clear the HIV virus in areas of the body that standard antiretroviral treatment is unable to reach. You will receive one of two potential intervention methods. One intervention method is a broadly neutralizing antibody that is given to control growth of the HIV virus and to increase the body’s immune system response. The second intervention method is an injection (IL-15 Superagonist) designed to awaken the immune system, activate any dormant HIV virus, and then kill the virus. The duration of this study is approximately 84-112 weeks pending on which intervention method you receive. There is compensation at each study visit for time and travel.
Contact: If interested, please email kspraggins@uabmc.edu or call 205-934-9346
Published in
Clinical Trials
June 13, 2024
3 chosen as UAB VIPs for second-quarter 2024
John Huffstutler, Nancy Parsons and Angel Simmons are the second-quarter 2024 honorees of the UAB Values in Action Program. Nominations for third-quarter 2024 honorees are open through July 11.
Published in
Awards & Honors
June 06, 2024
Updated training on fiscal responsibility to be required
“Understanding Your UAB Fiscal Responsibility,” which is focused on the role employees play in managing UAB’s financial resources, will be assigned to certain employees based on job function through the UAB Learning System beginning July 1, 2024.
Published in
Learning & Development
The UA System Board of Trustees awarded the rank of Distinguished Professor to Robert Brunner, Yogesh Dwivedi, Helen Krontiras, Cora Elizabeth Lewis, David M. Morris and Michele H. Nichols and the rank of University Professor to Marie Bakitas, Mirjam-Colette Kempf, Verna Keith, Michael Neiderweis and David Vance during its meeting in April 2024.
Published in
Awards & Honors
UAB kicks off its annual Summer of Wellness initiative June 1. This year, employees can get free access to the Campus Recreation Center throughout the entire month. Online registration is required to access the facility, as well as access to additional health and wellness opportunities including rewards for checking in throughout the month.
Published in
Benefits & Policies
May 28, 2024
We are looking for those with high blood pressure and a BMI over 30 to participate in a study
Participate in the PRECISION-BP research study investigating the best time to take blood pressure medication, morning or evening. This study participants will receive blood pressure medications for 28 days. Eligible participants must be obese (BMI: 30-45 kg/m2) men and women, have high blood pressure, and have no history of heart or kidney problems. The study involves wearing a blood pressure monitor for 24 hours, 24-hour inpatient visits at UAB Hospital, taking medications, and collecting blood and urine samples. Meals will be provided at no cost. Participants will be compensated $575 for completing the study visits. Please e-mail Haley at PRECISION-BPSTUDY@uabmc.edu or call us at 205-975-5825 if you are interested.
Published in
Clinical Trials
You may be eligible to participate in a research study looking at the effects of sacubitril/valsartan on how your body handles sugar. This medication is related to blood pressure and is safe to take with or without hypertension. Eligible participants must be healthy men and women, African American, and have no history of diabetes, heart disease or kidney problems. The study involves performing some exercise, taking sacubitril/valsartan, and collecting blood samples. Participants will be compensated $675 for completing all the visits. To participate, please contact Tiffany at 205-934-0534 or email us at nauticalstudy@uabmc.edu.
Published in
Clinical Trials
Eligible participants must be healthy adults (BMI less than 45 kg/m2) and have no history of diabetes, heart problems, or kidney problems. The study involves consuming prepared meals, performing exercise on a treadmill, undergoing a glucose test, and collecting blood, urine samples, and collection of genetic information. Participants will be compensated $300 for completing all the visits and meals will be provided at no cost. Please e-mail us at genesis@uabmc.edu or call us at (205) 975-3956 if you are interested.
Published in
Clinical Trials
According to the National Highway Traffic Safety Administration, auto thefts are a continued concern nationwide—and not just the contents inside the cars, but the cars themselves. These habits can help maintain a secure environment.
Published in
Campus Safety
May 17, 2024
Geurs named new School of Dentistry dean
Nicolaas Geurs, D.D.S., M.S., inaugural holder of UAB's Weatherford-Palcanis Endowed Professorship in Dentistry and the Dental Alumni-Joseph F. Volker Chair of Clinical Dentistry, has been selected as the next dean of the UAB School of Dentistry following a national search. He will begin his new role June 1.
Published in
Leadership
